Clinical Trials Browser

OTHER × fludarabine × Tumor-Agnostic × Clear all

NCT06043713 2025-12-19

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

Phase 1 Recruiting

Neoplasm Metastasis

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Phase EARLY_PHASE1 Recruiting

Carcinoma

NCT05601830 2024-11-06

Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease

Phase 1 Terminated

Neoplasm, Residual

NCT06013111 2024-02-21

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors

Phase 1 Recruiting

Carcinoma